Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
25.84
-0.96 (-3.58%)
Mar 5, 2026, 4:00 PM EST - Market closed
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.68 billion as of March 6, 2026. Its market cap has increased by 82.28% in one year.
Market Cap
1.68B
Enterprise Value
1.29B
1-Year Change
82.28%
Ranking
Category
Stock Price
$25.84
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.68B, an increase of 163.59%. That is a compound annual growth rate of 21.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 1.74B | -3.42% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.85B |
| Mesoblast | 1.83B |
| Olema Pharmaceuticals | 1.82B |
| Galecto | 1.81B |
| RAPT Therapeutics | 1.79B |
| Palvella Therapeutics | 1.78B |
| Zymeworks | 1.78B |
| Relay Therapeutics | 1.78B |